HomeCompareSLMAF vs MRK

SLMAF vs MRK: Dividend Comparison 2026

SLMAF yields 3.66% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLMAF wins by $1137.12M in total portfolio value
10 years
SLMAF
SLMAF
● Live price
3.66%
Share price
$6.58
Annual div
$0.24
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1137.18M
Annual income
$1,080,502,630.72
Full SLMAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SLMAF vs MRK

📍 SLMAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLMAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLMAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLMAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLMAF
Annual income on $10K today (after 15% tax)
$311.32/yr
After 10yr DRIP, annual income (after tax)
$918,427,236.11/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SLMAF beats the other by $918,418,907.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLMAF + MRK for your $10,000?

SLMAF: 50%MRK: 50%
100% MRK50/50100% SLMAF
Portfolio after 10yr
$568.62M
Annual income
$540,256,214.43/yr
Blended yield
95.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SLMAF
No analyst data
Altman Z
0.8
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLMAF buys
0
MRK buys
0
No recent congressional trades found for SLMAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLMAFMRK
Forward yield3.66%2.76%
Annual dividend / share$0.24$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1137.18M$56.8K
Annual income after 10y$1,080,502,630.72$9,798.13
Total dividends collected$1133.08M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SLMAF vs MRK ($10,000, DRIP)

YearSLMAF PortfolioSLMAF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,433$732.52$11,206$366.19+$227.00SLMAF
2$13,798$1,565.34$12,650$502.35+$1.1KSLMAF
3$18,295$3,531.30$14,407$694.19+$3.9KSLMAF
4$28,328$8,751.84$16,585$967.82+$11.7KSLMAF
5$55,640$25,329.07$19,342$1,363.89+$36.3KSLMAF
6$152,525$92,990.40$22,913$1,947.19+$129.6KSLMAF
7$639,676$476,474.39$27,662$2,823.89+$612.0KSLMAF
8$4,419,576$3,735,122.45$34,159$4,173.35+$4.39MSLMAF
9$52,964,969$48,236,022.69$43,337$6,308.80+$52.92MSLMAF
10$1,137,175,148$1,080,502,630.72$56,776$9,798.13+$1137.12MSLMAF

SLMAF vs MRK: Complete Analysis 2026

SLMAFStock

Sanlam Limited provides various financial solutions to individual, business, and institutional clients in South Africa, rest of Africa, and internationally. The company operates through Sanlam Life and Savings, Sanlam Emerging Markets, Sanlam Investment Group, and Santam segments. It offers life, disability, severe illness, income protection, funeral, credit life, health, short-term, medical, and group risk benefits, business debt, commercial insurance products; reinsurance products; financial planning and retirement, personal motor and property, solutions; investment products; wealth, and professionals and graduates insurance services; and personal and home loans, and credit cards. The company also provides payment and debit cards order collection, corporate credit, debt and equity structuring, business advice, risk management, and employee health and retirement plans for small and medium businesses, and self-employed professionals. The company was founded in 1918 and is headquartered in Bellville, South Africa.

Full SLMAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SLMAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLMAF vs SCHDSLMAF vs JEPISLMAF vs OSLMAF vs KOSLMAF vs MAINSLMAF vs JNJSLMAF vs ABBVSLMAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.